Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Tue Apr 01 18:22:09 GMT 2025
by
admin
on
Tue Apr 01 18:22:09 GMT 2025
|
| Protein Type | RECEPTOR |
| Protein Sub Type | |
| Sequence Origin | HUMAN |
| Sequence Type | COMPLETE |
| Record UNII |
KE3XSX7XYP
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
KE3XSX7XYP
Created by
admin on Tue Apr 01 18:22:09 GMT 2025 , Edited by admin on Tue Apr 01 18:22:09 GMT 2025
|
PRIMARY | |||
|
P32245
Created by
admin on Tue Apr 01 18:22:09 GMT 2025 , Edited by admin on Tue Apr 01 18:22:09 GMT 2025
|
PRIMARY |
| Glycosylation Type | HUMAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_3 |
| N | 1_17 |
| N | 1_26 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
AGONIST->OFF-TARGET |
Emax 87 at 10 micromolar
EC50
|
||
|
INHIBITOR -> TARGET |
|
||
|
AGONIST -> TARGET |
Sexual effects are thought to be related to its ability to activate the MC4 receptor (though the MC3 is thought to also possibly be involved).
Ki
|
||
|
AGONIST -> TARGET |
|
||
|
AGONIST -> TARGET |
|
||
|
|
AGONIST -> TARGET |
|
||
|
INHIBITOR -> TARGET |
Binding Assay
|
||
|
INHIBITOR -> TARGET |
BINDING
Ki
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT | CHEMICAL |
|
||||
| Molecular Formula | CHEMICAL |
|